The present application is generally directed to improvements in the oxygenation of a fluid, such as but not necessarily limited to water. There continues to be widespread interest in the production of fluids with a dissolved oxygen content. One effectual method for producing an oxygen enriched fluid is discussed in U.S. Pat. No. 6,821,438 to Hadley et al., assigned to the assignee of the present application and incorporated herein by reference.
In the Hadley patent, a fluid such as water is subjected to a processing sequence whereby the fluid and an injected oxygen content are passed through a high speed venturi assembly and subjected to a strong magnetic field. The oxygen absorption rate and longevity of the dissolved oxygen using this process has been demonstrated to be superior to other prior art oxygenation approaches.
With the continued consumer demand for fluids with a dissolved oxygen content, including but not limited to beverages such as water, there nevertheless remains a continual need for improvements in the manner in which oxygen can be dissolved in and retained by a fluid. It is to these and other improvements that various embodiments of the present invention are generally directed.
Various embodiments of the present invention are generally directed to a method and apparatus for oxygenation of a fluid.
In accordance with various embodiments, a vessel of water is provided for housing a population of fish. A stream of oxygenated water is generated to have a dissolved oxygen content of at least about 70 milligrams/liter (mg/l). The stream of oxygenated water is diluted with a second stream of water to provide an output stream with a dissolved oxygen content of from about 5 mg/l to about 14 mg/l. The output stream is injected into the vessel to maintain the population of fish.
These and other aspects of various embodiments of the present invention will become apparent in view of the following detailed discussion and the accompanying drawings.
While presently preferred embodiments are directed to the oxygenation of water, it will be appreciated that such is not limiting; for example, the system 100 of
A water source 102 is initially provided to supply water for the system 100. In some embodiments the water supplied by the source 102 is subjected to reverse osmosis processing. This so-called “RO water” may have a total dissolved solids (TDS) content on the order of around 5-20 parts per million (ppm, or milligrams/liter, mg/l). Other treatments of the water can be carried out at this stage as well, including the application of ultraviolet (UV) light, filtering, etc. to reduce microbe levels or otherwise condition the water for processing.
The water from the source 102 can be alternatively subjected to a deionization process to produce so-called “DI water” in which the water has substantially no TDS. In still other embodiments, the water is supplied from a municipal water treatment system, a natural spring, a stream, or some other source with appropriate preconditioning as desired. In general, it is desirable to specify and control within reasonable limits the characteristics of the initial water so that the various settings of the system 100 can be tuned for this initial water.
The water from the source 102 may be pumped by a pump 103 or otherwise supplied at an appropriate pressure, such as on the order of 50 pounds per square inch (psi), and supplied to a chiller 104. The chiller reduces the temperature of the water to an appropriate temperature level. The chiller 104 may utilize a compressed refrigerant or other mechanism to chill the water.
Generally, it has been found that colder water can be more receptive to the receipt and retention of dissolved oxygen. In some embodiments, the water is chilled to a well-controlled temperature level such as on the order of around 10 to 13 degrees Celsius (50-55 degrees Fahrenheit). The water may undergo a temperature reduction of on the order of about 6-14 degrees Celsius (10-25 degrees Fahrenheit) during the chilling operation. The water may pass through a series of serpentine conduits to increase dwell time and heat removal from the water in a constant flow process, or the water may be accumulated in a reservoir vessel and drawn therefrom as needed downstream.
The chilled water may be forwarded by a constant pressure liquid pump 105 to an ozone reaction tank 106. Although the system 100 shows the use of pumps 103, 105, it is contemplated that the liquid may also be supplied in the system 100 from an elevated reservoir, domestic power supply, etc. at a suitable initial pressure so that no additional pressure is required to drive the fluid through the system.
The reaction tank 106 introduces an amount of ozone (O3) into the water for anti-microbiological purposes. In some embodiments, a venturi 108 or other injection means can be used to introduce ozone from an ozone generator 110. Excess oxygen and ozone from the reaction tank 106 is released to the excess oxygen line to recover the remaining oxygen into an oxygen tank in a station 188.
The mixture of water and ozone passing out of the tank 106 is subjected to the introduction of colloidal minerals from a colloidal mineral source 112. As discussed more fully in the aforementioned Hadley patent, colloidal minerals provide electrostatic surface ion absorption characteristics that can enhance the ability of the water to absorb and retain injected oxygen. The amount and types of colloidal minerals added to the water will depend on the requirements of a given application.
In some embodiments, the colloidal minerals are obtained from TRC Nutritional Laboratories, Inc., Tulsa, Okla., USA under the trademark TRC Minerals®. A suitable formulation of 77LPPM TRC Minerals is set forth by the table in
The water and mineral mixture passes as a pressurized flow of fluid to an oxygen injection station 114. The station 114 operates to inject a flow of gaseous oxygen (O2) into the water at a selected rate and concentration to form a fluid/oxygen mixture. A block diffuser 116 can be used as shown in
As shown in
A pair of venturi assemblies are next depicted at 134, 136 in
Ceramic block magnets 152, 154 are be placed adjacent the second zone 142 to form an adjacent magnetic assembly so that the fluid passes through a strong magnetic field as it flows through the venturi assembly 134. Other forms of magnetic assemblies, such as rare earth magnets, electromagnets, can alternatively be used as desired. After being subjected to the magnetic field, the fluid exits the second zone 142 and enters a third zone 156. In some embodiments, the third zone 156 is the same diameter and cross-sectional shape as the first zone 140. As shown in
While each of the individual parallel paths in
The venturi assemblies operate as linear flow accelerators to accelerate the flow of the water/gas mixture to supersonic speeds. The speed of sound in the two-phase mixture of liquid and oxygen bubbles is on the order of around 15 meters per second (50 feet/sec), although this will vary depending on the concentrations of liquid and oxygen in the mixture. By comparison, the speed of sound in air is around 330 meters/sec (1,100 feet/sec) and the speed of sound in water is about 1,500 meters/sec (5,000 feet/sec).
The mixture is abruptly decelerated at the exit of each venturi assembly to return to subsonic speeds. The supersonic flow decelerates to subsonic flow across a thin region referred to as a shock wave. The shock wave breaks up the oxygen bubbles into microscopic size to promote mixing of the liquid and gas. Thus, subjecting the flow to two or more venturi assemblies in series as shown in
Continuing with
This provides a controlled gaseous space 172 above the liquid as well as an aeration action via the spillway of the middle partition barrier, depending on the relative levels of fluid on each side of the middle partition. A float valve assembly 174 is vertically actuated in relation to the fluid/gas level in the chamber 166. As the assembly 174 sinks, fluidic communication is established with a second outlet port 176. Thus, a liquid portion of the inlet fluid (with substantially dissolved oxygen) passes out of the first port 170 and the excess, non-dissolved gas passes out of the second port 176 for recovery and downstream reintroduction into the oxygenation process.
Continuing with the flow of
The liquid proceeds to a bottling system 180 which places appropriate amounts of the oxygenated water into bottles such as depicted at 182. The liquid passes a discharge control valve before being directed to the end application, e.g., the bottling system 180. An exemplary discharge pressure may be around 30 psi prior to the discharge control valve. A bypass path 184 allows excess oxygenated water to be returned to a suitable previous location in the process flow.
The excess gas from port 176 (
The system 100 of
As shown in
Because the tank water will accumulate waste components, a portion of the tank water can be output and provided to a water treatment block 210, which can carry out suitable treatment of the water including filtering, settling (including a septic system, etc.), antibacterial treatment, de-nitrification, CO2 removal, etc. The water treatment of block 210 could represent an inline treatment process, a local private treatment system, etc. The treated water or some component thereof can thereafter be incorporated into the dilution path 208. In this way, the amount of fresh water needed to sustain a population of fish 202 in the tank 200 can be significantly reduced over prior art systems.
A full scale (30 gallons per minute maximum) system conforming to that shown in
Total dissolved solids (TDS)=10 to 20 parts per million;
pH=6.1;
Initial dissolved oxygen levels=7.2 milligrams per liter; and
Temperature=14° C. (57° F.).
The chiller 104 reduced the temperature of the spring water to 10° C. (50° F.). The constant pressure liquid pump 105 supplied the spring water to the system at 292 kilopascal (42.4 psi) at a flow rate of 30 liters per minute (7.9 gallons per minute).
The piping for the piping network between the pump 105 and discharge to the bottling system 180 had a nominal diameter of 3.8 cm (1.5 inches). The ozone generator 110 supplied ozone via the venturi 108 to the ozone reaction tank 106 with a volume of 57 liters (15.1 gallons) and a maximum flow capacity of 150 liters per minute (39.6 gallons per minute). Following the ozone reaction tank 106 a positive displacement fluid metering pump 112 injects colloidal minerals into the flow via a diffuser. The colloidal minerals used were supplied by TRC Nutritional Laboratories as previously discussed in
The rate of colloidal minerals injected was regulated to give a TDS in the produced water between 30 and 50 ppm. The water and mineral mixture then passed to the oxygen injection station 114 where oxygen from the station 188 or the oxygen bottle source 190, or in combination, was injected via the block diffuser 116 at a pressure of about 64 kilopascals (9.3 psi) greater than the water pressure.
The resulting water/gas mixture then flowed through the passive mixer 128 (
After passing through the laminar flow grid 162, the liquid/gas mixture flowed into the 150 liter (39.6 gallon) gas/liquid separation tank 164 where excess non-dissolved oxygen gas was released through the second outlet port 176. Downstream from the gas/liquid separation tank 164, the flow passed through sensors for temperature, pressure and flow rate before being released through a flow control valve to a bottling arrangement where 0.5 liter bottles (16.9 oz) were filled at ambient pressure.
An initial test was performed to obtain an “initial” oxygen concentration in the water at the time of bottling. These “initial” samples showed DO values in excess of 60 mg/l, which is an out of range value for the handheld DO meter, indicating a substantially 10× increase in the DO value for the initial samples compared to the DO value before the oxygenation of the spring water.
Two boxes, each with 24 bottles of the bottled oxygenated water, were taken to Accurate Laboratories in Stillwater, Okla. for long term testing by an independent and certified laboratory. Representative results for these weekly tests are represented in
All samples exhibited enhanced DO concentration levels. The bottled oxygenated water kept at room temperature for 12 weeks showed a slight downward trend in DO concentrations over time, although all DO levels were at or greater than 38 mg/l at the end of the 12 week testing period. On the other hand, the bottled oxygenated water maintained in a refrigerated state exhibited consistent DO concentrations on the order of between about 50 mg/l and 60 mg/l, with little or no decrease in DO concentrations over the testing duration.
While some decrease in DO concentrations may be expected to eventually occur for refrigerated water kept longer that 12 weeks, it appears from
It will be appreciated that many other alternative embodiments and applications will readily occur to the skilled artisan in view of the foregoing discussion, so that the foregoing embodiments are merely illustrative of various embodiments, and are not limiting.
It is to be understood that even though numerous characteristics and advantages of various embodiments of the present invention have been set forth in the foregoing description, together with details of the structure and function of various embodiments of the invention, this detailed description is illustrative only, and changes may be made in detail, especially in matters of structure and arrangements of parts within the principles of the present invention to the full extent indicated by the broad general meaning of the terms in which the appended claims are expressed.
This application is a continuation of U.S. patent application Ser. No. 12/639,796 filed Dec. 16, 2009, now U.S. Pat. No. 8,142,550 which claims priority to U.S. Provisional Application No. 61/122,943 filed Dec. 16, 2008 which are hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
4060574 | Verner et al. | Nov 1977 | A |
4639340 | Garrett | Jan 1987 | A |
4645603 | Frankl | Feb 1987 | A |
4761228 | Weisenbarger et al. | Aug 1988 | A |
5302325 | Cheng | Apr 1994 | A |
5333465 | McBride | Aug 1994 | A |
5616250 | Johnson et al. | Apr 1997 | A |
5709799 | Engelhard | Jan 1998 | A |
5728287 | Hough et al. | Mar 1998 | A |
5766490 | Taylor et al. | Jun 1998 | A |
5814222 | Zelenak et al. | Sep 1998 | A |
5885467 | Zelenak et al. | Mar 1999 | A |
5904851 | Taylor et al. | May 1999 | A |
5925292 | Ziesenis | Jul 1999 | A |
6120008 | Littman et al. | Sep 2000 | A |
6250609 | Cheng et al. | Jun 2001 | B1 |
6279882 | Littman et al. | Aug 2001 | B1 |
6423236 | Shiota et al. | Jul 2002 | B1 |
6780331 | Galatro et al. | Aug 2004 | B2 |
6821438 | Hadley et al. | Nov 2004 | B2 |
6824695 | Tempest, Jr. | Nov 2004 | B2 |
6936179 | DeWald | Aug 2005 | B2 |
7100542 | Ehresman | Sep 2006 | B2 |
7168414 | Harvey | Jan 2007 | B2 |
7631615 | Mast | Dec 2009 | B1 |
20070062160 | Stadlmayr et al. | Mar 2007 | A1 |
20100270240 | Hebert et al. | Oct 2010 | A1 |
20100301498 | Matsumura et al. | Dec 2010 | A1 |
Number | Date | Country | |
---|---|---|---|
20120234254 A1 | Sep 2012 | US |
Number | Date | Country | |
---|---|---|---|
61122943 | Dec 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12639796 | Dec 2009 | US |
Child | 13429988 | US |